Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Fretzin

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|August 1, 1996
Ignition potential of the 585-nm pulsed-dye laser. Review of the literature and safety recommendationsS Fretzin, W H Beeson, C W Hanke
Gene|November 15, 1991
A Drosophila melanogaster H3.3 cDNA encodes a histone variant identical with the vertebrate H3.3S Fretzin, B D Allan, A van Daal, et al.
The British Journal of Dermatology|May 11, 2018
Efficacy and safety of ixekizumab in a randomized, double-blinded, placebo-controlled phase IIIb study of patients with moderate-to-severe genital psoriasisC Ryan, A Menter, L Guenther, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|August 1, 1996
Ignition potential of the 585-nm pulsed-dye laser. Review of the literature and safety recommendationsS Fretzin, W H Beeson, C W Hanke
Gene|November 15, 1991
A Drosophila melanogaster H3.3 cDNA encodes a histone variant identical with the vertebrate H3.3S Fretzin, B D Allan, A van Daal, et al.
The British Journal of Dermatology|May 11, 2018
Efficacy and safety of ixekizumab in a randomized, double-blinded, placebo-controlled phase IIIb study of patients with moderate-to-severe genital psoriasisC Ryan, A Menter, L Guenther, et al.
Pageof 1